Incidence of anxiety and depression in a predominantly HIV-infected population with severe adverse drug reactions

Zitha, Eddy ; Chiliza, Bonga ; Muloiwa, Rudzani ; Lehloenya, Rannakoe (2014-07)

CITATION: Zitha, E., Chiliza, B., Muloiwa, R. & Lehloenya, R. 2014. Incidence of anxiety and depression in a predominantly HIV-infected population with severe adverse drug reactions. Clinical and Translational Allergy, 4(Suppl 3):P95, doi:10.1186/2045-7022-4-S3-P95.

The original publication is available at http://www.ctajournal.com/content/4/S3/P95

Article

Background Little is known on the short-term or medium-term psychological and psychiatric sequelae following Stevens Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and drug reaction with eosinophilia and systemic symptoms (DRESS). Based on this we did a prospective study designed to assess anxiety and depression in patients with severe cutaneous adverse drug reactions by indicating higher Hospital anxiety and depression scale (HADS).

Please refer to this item in SUNScholar by using the following persistent URL: http://hdl.handle.net/10019.1/95512
This item appears in the following collections: